Results of tadalafil treatment in patients following an open nerve-sparing radical prostatectomy


Submitted: July 28, 2015
Accepted: October 13, 2015
Published: March 31, 2016
Abstract Views: 2675
PDF: 1385
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Erkan Hirik Erzincan University Mengücek Gazi Education and Research Hospital, Urology Clinic, Turkey.
  • Aliseydi Bozkurt Erzincan University Mengücek Gazi Education and Research Hospital, Urology Clinic, Turkey.
  • Mehmet Karabakan Erzincan University Mengücek Gazi Education and Research Hospital, Urology Clinic, Turkey.
  • Özkan Onuk Gaziosmanpasa Taksim Education and Research Hospital, Urology Clinic, Turkey.
  • Mustafa Bahadır Can Balcı Gaziosmanpasa Taksim Education and Research Hospital, Urology Clinic, Turkey.
  • Memduh Aydın Gaziosmanpasa Taksim Education and Research Hospital, Urology Clinic, Turkey.
  • Murat Çakan Erzincan University Mengücek Gazi Education and Research Hospital, Urology Clinic, Turkey.
  • Barıs Nuhoglu Erzincan University Mengücek Gazi Education and Research Hospital, Urology Clinic, Turkey.
Purpose: To evaluate the effect of postoperatively administering a low daily dose of tadalafil on the erectile function of patients who underwent a nerve-sparing radical prostatectomy(NSRP) due to localized prostate cancer (PCa). Materials and Methods: Of 138 patients, who underwent NSRP due to PCa between 2012 and 2014, 55 patients who had not had pre-operative erectile dysfunction (ED) were included in the study. The mean age of the patients was 64 (54-72). On the 15th day after surgery, after ultrasound evaluation, all 55 patients started on a daily dose of 5 mg tadalafil that was continued for 2.5 months. The erectile function of patients was evaluated pre-operatively, post-operatively, and at the 3rd and 6th month after surgery using the International Index of Erectile Function (IIEF-5) test. None of the patients was treated with hormonal therapy or radiotherapy before or after surgery. Results: Three patients were excluded from the study due to the adverse effects of tadalafil and two patients elected to discontinue the treatment. Of the remaining 50 patients whose pre-operative erectile function had been found normal, at 3 months after surgery, 36 (72%) had normal erectile function; of the remaining patients in the study six (12%) presented with mild, two (4%) with moderate, and six (12%) with severe ED. Six months after surgery, 35 patients (70%) had normal erectile function while seven (14%) had mild, three (6%) moderate and five (10%) severe ED. There was no statistically significant difference between the results obtained at the 3rd and 6thmonth follow-up (p > 0.05). Three patients reported adverse effects with tadalafil including flushes in 2 (3.6%) and a headache in 1 (1.8%). Conclusions: The administration of a 5 mg post-operative dose of tadalafil to patients that had undergone a bilateral NSRP was found to have a positive effect on the recovery and maintenance of erectile function. However, there is still a need to investigate a larger series of cases.

Hirik, E., Bozkurt, A., Karabakan, M., Onuk, Özkan, Balcı, M. B. C., Aydın, M., Çakan, M., & Nuhoglu, B. (2016). Results of tadalafil treatment in patients following an open nerve-sparing radical prostatectomy. Archivio Italiano Di Urologia E Andrologia, 88(1), 4–6. https://doi.org/10.4081/aiua.2016.1.4

Downloads

Download data is not yet available.

Citations